UB Paderborn / Katalog / Suche / in CDI

The use of fractional polynomials to model continuous risk variables in epidemiology

International journal of epidemiology, 1999-10, Vol.28 (5), p.964-974

1999

Volltextzugriff (PDF)

Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs

Computational statistics & data analysis, 2006-08, Vol.50 (12), p.3464-3485

2006

Volltextzugriff (PDF)

REporting recommendations for tumour MARKer prognostic studies (REMARK)

British journal of cancer, 2005-08, Vol.93 (4), p.387-391

2005

Volltextzugriff (PDF)

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines

British journal of cancer, 2010-01, Vol.102 (1), p.173-180

2010

Volltextzugriff (PDF)

Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond

British journal of cancer, 2009-04, Vol.100 (8), p.1219-1229

2009

Volltextzugriff (PDF)

Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study

Journal of clinical oncology, 2002-12, Vol.20 (24), p.4628-4635

2002

Volltextzugriff (PDF)

Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials

Journal of the Royal Statistical Society. Series A, Statistics in society, 1999, Vol.162 (1), p.71-94

1999

Volltextzugriff (PDF)

Traditional reviews, meta-analyses and pooled analyses in epidemiology

International journal of epidemiology, 1999-02, Vol.28 (1), p.1-9

1999

Volltextzugriff (PDF)

Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation

Statistics in medicine, 2003-02, Vol.22 (4), p.639-659

2003

Volltextzugriff (PDF)

Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence

European journal of cancer (1990), 2010, Vol.46 (1), p.95-101

2010

Volltextzugriff (PDF)

Information from CTC measurements for metastatic breast cancer prognosis—we should do more than selecting an “optimal cut point”

Breast cancer research and treatment, 2010-07, Vol.122 (1), p.219-220

2010

Volltextzugriff (PDF)

Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2 × 2 randomised clinical trial in patients with low risk of recurrence

European journal of cancer (1990), 2010-01, Vol.46 (1), p.95-101

2010

Volltextzugriff (PDF)

Overinterpretation and misreporting of prognostic factor studies in medical oncology

European journal of cancer (1990), 2016-12, Vol.69, p.S64-S64

2016

Volltextzugriff (PDF)

Building multivariable regression models with continuous covariates in clinical epidemiology--with an emphasis on fractional polynomials

Methods of information in medicine, 2005, Vol.44 (4), p.561

2005

Volltextzugriff (PDF)

Dangers of Using “Optimal” Cutpoints in the Evaluation of Prognostic Factors

JNCI : Journal of the National Cancer Institute, 1994-06, Vol.86 (11), p.829-835

1994

Volltextzugriff (PDF)

Improving the robustness of fractional polynomial models by preliminary covariate transformation: A pragmatic approach

Computational statistics & data analysis, 2007-05, Vol.51 (9), p.4240-4253

2007

Volltextzugriff (PDF)

Dose-response modelling for bivariate covariates with and without a spike at zero: theory and application to binary outcomes

Statistica Neerlandica, 2015-11, Vol.69 (4), p.374-398

2015

Volltextzugriff (PDF)

Adding local components to global functions for continuous covariates in multivariable regression modeling

Statistics in medicine, 2010-03, Vol.29 (7-8), p.808-817

2010

Volltextzugriff (PDF)

Dichotomizing continuous predictors in multiple regression: a bad idea

Statistics in medicine, 2006-01, Vol.25 (1), p.127-141

2006

Volltextzugriff (PDF)

Survival analyses from the ZEBRA study: goserelin (Zoladex™) versus CMF in premenopausal women with node-positive breast cancer

European journal of cancer (1990), 2003-08, Vol.39 (12), p.1711-1717

2003

Volltextzugriff (PDF)

Quality of Life in Goserelin-Treated Versus Cyclophosphamide + Methotrexate + Fluorouracil–Treated Premenopausal and Perimenopausal Patients With Node-Positive, Early Breast Cancer: The Zoladex Early Breast Cancer Research Association Trialists Group

Journal of clinical oncology, 2003-12, Vol.21 (24), p.4510-4516

2003

Volltextzugriff (PDF)

Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)

Osteoporosis international, 2003-12, Vol.14 (12), p.1001-1006

2003

Volltextzugriff (PDF)

Multivariate analysis of flow data in breast lesions and validation in a normal clinical setting

Ultraschall in der Medizin, 2011-10, Vol.32 (5), p.511

2011

Volltextzugriff (PDF)

A new measure of prognostic separation in survival data

Statistics in medicine, 2004-03, Vol.23 (5), p.723-748

2004

Volltextzugriff (PDF)

An experimental evaluation of boosting methods for classification

Methods of information in medicine, 2010-01, Vol.49 (3), p.219

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The use of fractional polynomials to model continuous risk variables in epidemiology

Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs

REporting recommendations for tumour MARKer prognostic studies (REMARK)

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines

Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond

Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study

Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials

Traditional reviews, meta-analyses and pooled analyses in epidemiology

Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation

Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence

Information from CTC measurements for metastatic breast cancer prognosis—we should do more than selecting an “optimal cut point”

Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2 × 2 randomised clinical trial in patients with low risk of recurrence

Overinterpretation and misreporting of prognostic factor studies in medical oncology

Building multivariable regression models with continuous covariates in clinical epidemiology--with an emphasis on fractional polynomials

Dangers of Using “Optimal” Cutpoints in the Evaluation of Prognostic Factors

Improving the robustness of fractional polynomial models by preliminary covariate transformation: A pragmatic approach

Dose-response modelling for bivariate covariates with and without a spike at zero: theory and application to binary outcomes

Adding local components to global functions for continuous covariates in multivariable regression modeling

Dichotomizing continuous predictors in multiple regression: a bad idea

Survival analyses from the ZEBRA study: goserelin (Zoladex™) versus CMF in premenopausal women with node-positive breast cancer

Quality of Life in Goserelin-Treated Versus Cyclophosphamide + Methotrexate + Fluorouracil–Treated Premenopausal and Perimenopausal Patients With Node-Positive, Early Breast Cancer: The Zoladex Early Breast Cancer Research Association Trialists Group

Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)

Multivariate analysis of flow data in breast lesions and validation in a normal clinical setting

A new measure of prognostic separation in survival data

An experimental evaluation of boosting methods for classification

Suchergebnisse filtern